Protein Profiling with Epstein-Barr Nuclear Antigen-1 Reveals an Interaction with the Herpesvirus-associated Ubiquitin-specific Protease HAUSP/USP7
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The Epstein-Barr nuclear antigen-1 (EBNA1) protein of Epstein-Barr virus is important for the replication, segregation, and transcriptional activation of latent Epstein-Barr virus genomes; has been implicated in host cell immortalization; and avoids proteasomal processing and cell-surface presentation. To gain insight into how EBNA1 fulfills these functions, we have profiled cellular protein interactions with EBNA1 using EBNA1 affinity chromatography and tandem affinity purification (TAP) of EBNA1 complexes from human cells (TAP-tagging). We discovered several new specific cellular protein interactions with EBNA1, including interactions with HAUSP/USP7, NAP1, template-activating factor-I beta/SET, CK2, and PRMT5, all of which play important cell regulatory roles. The ubiquitin-specific protease USP7 is a known target of herpes simplex virus, and the USP7-binding region of EBNA1 was mapped to amino acids 395-450. A mutation in EBNA1 that selectively disrupted binding to USP7 was found to cause a 4-fold increase in EBNA1 replication activity but had no effect on EBNA1 turnover and cell-surface presentation. The results suggest that USP7 can regulate the replication function of EBNA1 and that EBNA1 may influence cellular events by sequestering key regulatory proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“upon transfection of human epithelial cells (HeLa) with the TAP-tagged viral protein EBNA1 from the herpesvirus Epstein–Barr virus (EBV), Holowaty et al. identified a stable interaction with the cellular deubiquitinating protease USP7/HAUSP [71].”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [71]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which additionally demonstrated that the EBNA1-USP7 interaction does not require other human proteins.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [71]
In the citing paper
“The discovered EBNA1-USP7 interaction was confirmed by co-immunoprecipitation in insect cells”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [71]
In the citing paper
“Subsequent functional assays further suggested that the virus may sequester USP7 indirectly to inhibit host-induced apoptosis and promote cell cycle growth.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A generic protein purification method for protein complex characterization and proteome exploration
Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M., & Séraphin, B. (1999) · Nature Biotechnology · doi:10.1038/13732 · Cited by 2,707
RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
Hoege, C., Pfander, B., Moldovan, G.-L., Pyrowolakis, G., & Jentsch, S. (2002) · Nature · doi:10.1038/nature00991 · Cited by 2,198
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
Yates, J. L., Warren, N., & Sugden, B. (1985) · Nature · doi:10.1038/313812a0 · Cited by 1,292
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
LITCHFIELD, D. W. (2003) · Biochemical Journal · doi:10.1042/bj20021469 · Cited by 1,233
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Use of mass spectrometric molecular weight information to identify proteins in sequence databases
Mann, M., Højrup, P., & Roepstorff, P. (1993) · Biological Mass Spectrometry · doi:10.1002/bms.1200220605 · Cited by 931
Transport into and out of the Nucleus
Macara, I. G. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.4.570-594.2001 · Cited by 905
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., & Masucci, M. G. (1995) · Nature · doi:10.1038/375685a0 · Cited by 823
Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A., & Masucci, M. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12616 · Cited by 562
Everett, R. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1519 · Cited by 492
Research works printed but not linked: 4
- 1. Kieff, E. ∙ Rickinson, A.B. Knipe, D.M. ∙ Howley, P.M. (Editors) Fields Virology Lippincott-Williams & Wilkins, Philadelphia, 2001; 2511-2573 Google Scholar
- 4. Reisman, D. ∙ Yates, J. ∙ Sugden, B. Mol. Cell. Biol. 1985; 5:1822-1832 Crossref Scopus (354) PubMed Google Scholar
- 6. Reisman, D. ∙ Sugden, B. Mol. Cell. Biol. 1986; 6:3838-3846 Crossref Scopus (297) PubMed Google Scholar
- Xiao, 1994, Mol. Cell. Biol., 14, 7507
Cited by
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679
Structure of the p53 Binding Domain of HAUSP/USP7 Bound to Epstein-Barr Nuclear Antigen 1
Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M. N., Shire, K., Nguyen, T., Zhang, R. G., Liao, J., Lee, W., Edwards, A. M., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.029 · Cited by 360
Self-citationEpstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 361
“EBNA-1 a.a. 395 – 450 binds to host USP7 (ubiquitin-speci fi c protease 7) 148 and forms a quaternary complex with USP7, GMPSC and EBV oriP DNA, 153 and this interaction alters histone modi fi cation at oriP, disrupts p53 and also the PML levels.”
BackgroundAffinity-purification coupled to mass spectrometry: basic principles and strategies
Dunham, W. H., Mullin, M., & Gingras, A. (2012) · PROTEOMICS · doi:10.1002/pmic.201100523 · Cited by 368
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0097 · Cited by 321
“USP7 has been shown to interact with viral proteins, such as ICP0 (Vmw 110), a herpes simplex virus immediate-early gene stimulating initiation of the viral lytic cycle (8), and Epstein-Barr nuclear antigen-1 (9).”
BackgroundMolecular recognition of p53 and MDM2 by USP7/HAUSP.
Sheng, Y., Saridakis, V., Sarkari, F., Duan, S., Wu, T., Arrowsmith, C. H., & Frappier, L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1067 · Cited by 315
“USP7 also binds the Epstein-Barr nuclear antigen-1 (EBNA1) protein from Epstein-Barr virus (EBV), which has several important roles in latent EBV infectio”
BackgroundSelf-citationBougdour, A., Durandau, E., Brenier-Pinchart, M.-P., Ortet, P., Barakat, M., Kieffer, S., Curt-Varesano, A., Curt-Bertini, R.-L., Bastien, O., Coute, Y., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.03.002 · Cited by 258
“…as an interacting protein of first the herpes simplex virus protein 498 Cell Host & Microbe 13, 489–500, April 17, 2013 ª2013 Elsevier ICP0 (infected cell protein 0) (Everett et al., 1997) and then of the Epstein-Barr viral protein, EBNA1 (Epstein-Barr nuclear antigen-1) (Holowaty et al., 2003).”
BackgroundHussain, S., Zhang, Y., & Galardy, P. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8739 · Cited by 260
Hu, M., Gu, L., Li, M., Jeffrey, P. D., Gu, W., & Shi, Y. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040027 · Cited by 251
“In EBNA1 peptide, the N-terminal Pro442 and Gly443 run parallel to the edge of the HAUSP b7 strand, forming hydrogen bonds between the carbonyl group of Asp441 and the side chain of Asn169 in HAUSP and between the carbonyl group of EBNA1 Pro442 and the amide group of Ser168 in HAUSP [30].”
InfluentialThe Multifaceted Roles of USP7: New Therapeutic Opportunities
Nicholson, B., & Suresh Kumar, K. G. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9185-5 · Cited by 240
“EBNA1 interacts with and often sequesters several host cell proteins including USP7 [ 54 ].”
BackgroundDiscovery and characterization of highly potent and selective allosteric USP7 inhibitors
Gavory, G., O'Dowd, C. R., Helm, M. D., Flasz, J., Arkoudis, E., Dossang, A., Hughes, C., Cassidy, E., McClelland, K., Odrzywol, E., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2528 · Cited by 224
Regulation of proteolysis by human deubiquitinating enzymes
Eletr, Z. M., & Wilkinson, K. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.027 · Cited by 183
Cytomegalovirus Immune Evasion
Powers, C., DeFilippis, V., Malouli, D., & Früh, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_19 · Cited by 185
Protein partners of deubiquitinating enzymes
Ventii, K. H., & Wilkinson, K. D. (2008) · Biochemical Journal · doi:10.1042/bj20080798 · Cited by 185
Protein Interaction Domains of the Ubiquitin-specific Protease, USP7/HAUSP
Holowaty, M. N., Sheng, Y., Nguyen, T., Arrowsmith, C., & Frappier, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307200200 · Cited by 182
Self-citationUSP7: Structure, substrate specificity, and inhibition
Pozhidaeva, A., & Bezsonova, I. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.02.005 · Cited by 178
Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1
Tellam, J., Connolly, G., Green, K. J., Miles, J. J., Moss, D. J., Burrows, S. R., & Khanna, R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040191 · Cited by 160
“1425 Tellam et al. sults are supported by recent studies by Holowaty et al. ( 28 ) who showed that EBNA1 interacts with a Ub-specific protease, HAUSP/USP7, which is demonstrated to deubiquitinate EBNA1.”
ResultSelf-citationGao, G., & Luo, H. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-144 · Cited by 168
Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells
Huang, Z., Wu, Q., Guryanova, O. A., Cheng, L., Shou, W., Rich, J. N., & Bao, S. (2011) · Nature Cell Biology · doi:10.1038/ncb2153 · Cited by 161
“Here, we demonstrate that the herpesvirus-associated ubiquitin-specific protease (HAUSP; also known as ubiquitin-specific protease 7, USP7; refs&nbs”
Sivachandran, N., Sarkari, F., & Frappier, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000170 · Cited by 151
“Where indicated, the same plasmid expressing EBNA1 mutants D325– 376 or D395–450 was used [13,54], and the same plasmid lacking EBNA1 cDNA (pc3OriP) was used as a negative control [53].”
BackgroundMethodInfluentialSelf-citationCanning, M., Boutell, C., Parkinson, J., & Everett, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402885200 · Cited by 143
Wood, V. H. J., O’Neil, J. D., Wei, W., Stewart, S. E., Dawson, W. O., & Young, L. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210496 · Cited by 165
Deubiquitinases and the new therapeutic opportunities offered to cancer
Pfoh, R., Lacdao, I. K., & Saridakis, V. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0516 · Cited by 163
“…to interact with the EBNA1 protein from Epstein–Barr virus, vIRF4 and LANA proteins from Kaposi’s sarcoma herpesvirus, UL35 from cytomegalovirus, and E1B-55K from adenovirus (Holowaty et al. 2003, Saridakis et al. 2005, Lee et al. 2011, Jager et al. 2012, Salsman et al. 2012, Ching et al. 2013).”
BackgroundWang, Z., Kang, W.-T., Li, O., Qi, F., Wang, J., You, Y., He, P., Suo, Z., Zheng, Y., & Liu, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.005 · Cited by 145
Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
Frappier, L. (2012) · Viruses · doi:10.3390/v4091537 · Cited by 137
“Saridakis, V.; Sheng, Y.; Sarkari, F.; Holowaty, M.N.; Shire, K.; Nguyen, T.; Zhang, R.G.; Liao, J.; Lee, W.; Edwards, A.M.; et al. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein–Barr nuclear antigen 1 implications for EBV-mediated immortalization.”
BackgroundInfluentialSelf-citationMessick, T. E., Smith, G. R., Soldan, S. S., McDonnell, M. E., Deakyne, J. S., Malecka, K. A., Tolvinski, L., van den Heuvel, A. P. J., Gu, B.-W., Cassel, J. A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5612 · Cited by 134
USP7: Novel Drug Target in Cancer Therapy
Wang, Z., Kang, W., You, Y., Pang, J., Ren, H., Suo, Z., Liu, H., & Zheng, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00427 · Cited by 126
“The 4395–450 mutant that selectively disrupted the binding to USP7 was found to increase fourfold EBNA1 replication activity than wild-type, but performed no impact on EBNA1 turnover and cell-surface presentation (Holowaty et al., 2003).”
BackgroundInfluentialTargeting ubiquitin specific proteases for drug discovery
Daviet, L., & Colland, F. (2008) · Biochimie · doi:10.1016/j.biochi.2007.09.013 · Cited by 126
Functions of the Epstein-Barr Virus EBNA1 Protein in Viral Reactivation and Lytic Infection
Sivachandran, N., Wang, X., & Frappier, L. (2012) · Journal of Virology · doi:10.1128/jvi.00013-12 · Cited by 126
Self-citationMaxwell, K. L., & Frappier, L. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00042-06 · Cited by 120
“A TAP tagging approach was also used to assess stable host cell interactions formed by EBNA1 when expressed in human cells (44).”
BackgroundMethodSelf-citationShi, D., & Grossman, S. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.8.13417 · Cited by 132
Saha, A., Murakami, M., Kumar, P., Bajaj, B. G., Sims, K., & Robertson, E. S. (2009) · Journal of Virology · doi:10.1128/jvi.02408-08 · Cited by 129
Sarkari, F., Sanchez-Alcaraz, T., Wang, S., Holowaty, M. N., Sheng, Y., & Frappier, L. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000624 · Cited by 115
“This is consistent with our previous observation that the EBNA1 mutant that fails to bind USP7 has decreased transcriptional activation function [14].”
BackgroundMethodResultInfluentialSelf-citationYi, F., Saha, A., Murakami, M., Kumar, P., Knight, J. S., Cai, Q., Choudhuri, T., & Robertson, E. S. (2009) · Virology · doi:10.1016/j.virol.2009.03.027 · Cited by 124
“The role of EBV latent antigens in regulating p53 has so far been elusive in the context of latency III; however studies have sown that EBNA1 can protect infected cells from apoptosis by lowering the levels of p53 via interaction with a deubiquitination enzyme (Holowaty and Frappier, 2004; Holowaty et al., 2003; Sarid…”
BackgroundInfluentialLum, K. K., & Cristea, I. M. (2016) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1147353 · Cited by 113
“identified a stable interaction with the cellular deubiquitinating protease USP7/HAUSP [71].”
BackgroundLu, J. L., Murakami, M., Verma, S. C., Cai, Q., Haldar, S., Kaul, R., Wasik, M. A., Middeldorp, J. M., & Robertson, E. S. (2010) · Virology · doi:10.1016/j.virol.2010.10.029 · Cited by 111
“Cells werewashedwith 1× PBS and EBNA1were detected using rabbit serum raised against EBNA1 (Holowaty et al., 2003) followedbydetectionusing anti-rabbit Alexa Fluor 488 (Molecular Probes, Eugene, OR).”
MethodInfluentialThe Epstein-Barr Virus EBNA1 Protein
Frappier, L. (2012) · Scientifica · doi:10.6064/2012/438204 · Cited by 125
“However, deletion of EBNA1 residues 61–83 or 395–450 has been observed to increase replication efficiency [29, 30], and, consistent with these results, a point mutation within each of these regions (G81 and G425) causes a similar enhancement of EBNA1-dependent DNA replication [31]. ese point…”
BackgroundSelf-citationThe EBNA1 Protein of Epstein-Barr Virus Functionally Interacts with Brd4
Lin, A., Wang, S., Nguyen, T., Shire, K., & Frappier, L. (2008) · Journal of Virology · doi:10.1128/jvi.01680-08 · Cited by 99
“with the 325–376 region that might mediate its transcriptional effects (18, 50, 55), but to this point, protein interactions with the 61–83 region that are likely to be important for transcription have not been identified.”
BackgroundSelf-citationContributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma
Sivachandran, N., Dawson, W. O., Young, L. S., Liu, F., Middeldorp, J. M., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05623-11 · Cited by 103
Self-citationEpstein-Barr Virus Nuclear Antigen 1 Hijacks the Host Kinase CK2 To Disrupt PML Nuclear Bodies
Sivachandran, N., Cao, J. Y., & Frappier, L. (2010) · Journal of Virology · doi:10.1128/jvi.01183-10 · Cited by 103
“CK2 was found to interact with EBNA1 in both in vivo TAP-tagging experiments and in vitro affinity column experiments using human cell lysates (22).”
BackgroundMethodSelf-citationXu, X., Song, Y., Li, Y., Chang, J., zhang, H., & An, L. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2010.04.009 · Cited by 99
“[30] expressed EBNA1 in fusion with a TAP tag at the C-terminus in human 293T cells.”
BackgroundWilson, J. B., Manet, É., Gruffat, H., Busson, P., Blondel, M., & Fåhræus, R. (2018) · Cancers · doi:10.3390/cancers10040109 · Cited by 106
Fernández‐Montalván, A., Bouwmeester, T., Joberty, G., Mader, R., Mahnke, M., Pierrat, B., Schlaeppi, J., Worpenberg, S., & Gerhartz, B. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05952.x · Cited by 96
The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection
Calistri, A., Munegato, D., Carli, I., Parolin, C., & Palù, G. (2014) · Cells · doi:10.3390/cells3020386 · Cited by 104
Role of EBNA1 in NPC tumourigenesis
Frappier, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.002 · Cited by 95
“Destabilization of p53 Proteomics methods revealed a stable interaction between BNA1 and a cellular ubiquitin-specific protease called USP7 or AUSP [91].”
BackgroundSelf-citationVoo, K. S., Peng, G., Guo, Z., Fu, T., Li, Y., Frappier, L., & Wang, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2552 · Cited by 92
Self-citationInteraction of Epstein-Barr virus (EBV) with human B-lymphocytes
Klein, G., Klein, E., & Kashuba, E. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.146 · Cited by 89
“[25]; NM23-H1 [30]; BRD4 [31]”
BackgroundFrappier, L. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_1 · Cited by 113
Self-citationKapoor, P., Lavoie, B. D., & Frappier, L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4934-4945.2005 · Cited by 85
“anti-USP7 rabbit serum as a loading control (22) and with either rabbit anti-”
Self-citationJiang, L., Xie, C., Lung, H. L., Lo, K. W., Law, G., Mak, N. K., & Wong, K. (2018) · Theranostics · doi:10.7150/thno.26823 · Cited by 82
“Notably, EBNA1 has a long half-life, which is usually more than 24 h [54, 123], so it requires a relatively long time for treatment by inhibitors in a viability assay.”
BackgroundInfluentialBilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein
Lee, H.-R., Choi, W.-C., Lee, S., Hwang, J., Hwang, E., Guchhait, K., Haas, J., Toth, Z., Jeon, Y. H., Oh, T.-K., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2142 · Cited by 82
“An Epstein-Barr virus (EBV) viral protein, Epstein-Barr nuclear antigen 1 ( EBNA1 ), also binds the same region of HAUSP as that bound by the MDM2 and p53 peptides, competitively blocking these cellular interaction”
BackgroundShire, K., Kapoor, P., Jiang, K., Hing, M. N. T., Sivachandran, N., Nguyen, T., & Frappier, L. (2006) · Journal of Virology · doi:10.1128/jvi.02682-05 · Cited by 82
“We have previously examined cellular protein interactions with EBNA1 using an in vivo TAP-tagging approach as well as an EBNA1 affinity column approach (23).”
BackgroundMethodSelf-citationCao, J. Y., Mansouri, S., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05648-11 · Cited by 81
Self-citationThe Ubiquitin-Specific Peptidase USP15 Regulates Human Papillomavirus Type 16 E6 Protein Stability
Vos, R. M., Altreuter, J., White, E. A., & Howley, P. M. (2009) · Journal of Virology · doi:10.1128/jvi.00605-09 · Cited by 77
“For instance, USP7 (or HAUSP) interacts with the herpes simplex virus type I immediate early protein ICP0 (4, 6) as well as the Epstein-Barr virus protein EBNA1 (13).”
BackgroundDeng, Z., Atanasiu, C., Zhao, K., Marmorstein, R., Sbodio, J. I., Chi, N., & Lieberman, P. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4640-4650.2005 · Cited by 78
“A protein profiling study of EBNA1 complexes found that the interaction with the ubiquitin protease HAUSP was dependent upon EBNA1 amino acid residues 395 to 440, a region which overlaps with one of the TNKS interaction motifs (19, 20).”
BackgroundEpstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice
Kang, M.-S., Lu, H., Yasui, T., Sharpe, A. H., Warren, H. S., Cahir-McFarland, E. D., Bronson, R. T., Hung, S. C., & Kieff, E. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408774102 · Cited by 78
Cancers associated with human gammaherpesviruses
Wen, K. W., Wang, L., Menke, J. R., & Damania, B. (2021) · FEBS Journal · doi:10.1111/febs.16206 · Cited by 136
Epstein-Barr Virus EBNA1 Protein Regulates Viral Latency through Effects on let-7 MicroRNA and Dicer
Mansouri, S., Pan, Q., Blencowe, B. J., Claycomb, J. M., & Frappier, L. (2014) · Journal of Virology · doi:10.1128/jvi.01785-14 · Cited by 80
“rum at 1:1,000 [17] or OT1X [51] at 1:2,000), -actin (1:1,000; catalog no.”
Self-citationSalsman, J., Jagannathan, M., Paladino, P., Chan, P.-K., Dellaire, G., Raught, B., & Frappier, L. (2012) · Journal of Virology · doi:10.1128/jvi.05442-11 · Cited by 73
“Unlike ICP0, EBNA1 interacts with the N-terminal TRAF domain of USP7 and acts as a competitive inhibitor of USP7 association with the tumor suppressor p53 (30).”
BackgroundSelf-citationvan der Knaap, J. A., Kozhevnikova, E. N., Langenberg, K. P. S., Moshkin, Y. M., & Verrijzer, C. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01121-09 · Cited by 74
“Several other associated factors and substrates of USP7 have been identified, including p53 (16), Epstein-Barr nuclear antigen 1 (EBNA1) (12), MDM2 (15), DAXX (26), FOXO4 (28), and PTEN (25).”
A role for USP7 in DNA replication.
Jagannathan, M., Nguyen, T., Gallo, D., Luthra, N., Brown, G. W., Saridakis, V., & Frappier, L. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00639-13 · Cited by 71
Self-citationPotential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
Smith, D. W., & Sugden, B. (2013) · Viruses · doi:10.3390/v5010226 · Cited by 69
“EBNA1 is also reported to interact with the protein kinase CK2 (Figure 1) and through this interaction disrupt PML nuclear bodies and degrade PML proteins [35,64,65].”
BackgroundJäger, W., Santag, S., Weidner-Glunde, M., Gellermann, E., Kati, S., Pietrek, M., Viejo-Borbolla, A., & Schulz, T. F. (2012) · Journal of Virology · doi:10.1128/jvi.06840-11 · Cited by 64
“An EBNA-1 mutant unable to interact with USP7 shows increased replication of the latent EBV origin and decreased transcriptional activation but has no effect on the segregation function of EBNA-1 (19).”
BackgroundResultInfluentialIdentification and Characterization of USP7 Targets in Cancer Cells
Georges, A., Marcon, E., Greenblatt, J., & Frappier, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-34197-x · Cited by 63
Self-citationEdelmann, M. J., & Kessler, B. M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.010 · Cited by 65
“However, despite that these interactions have been studied in detail [28], their functional significance is not yet completely understood.”
BackgroundEBNA1 and host factors in Epstein–Barr virus latent DNA replication
Frappier, L. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.09.005 · Cited by 65
Self-citationSakwe, A. M., Nguyen, T., Athanasopoulos, V., Shire, K., & Frappier, L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02384-06 · Cited by 65
“Although this method was originally developed for use in yeast (32), we have found the approach to be extremely useful for detecting stable interactions in human cells when coupled with mass spectroscopy (10).”
MethodSelf-citationTumor Viruses and Cell Signaling Pathways: Deubiquitination versus Ubiquitination
Shackelford, J., & Pagano, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5089-5093.2004 · Cited by 67
“teracts with HAUSP, and this interaction influences EBNA1 transcriptional activity (40, 41).”
BackgroundDual-utility NLS drives RNF169-dependent DNA damage responses
An, L., Jiang, Y., Ng, H. H. W., Man, E. P. S., Chen, J., Khoo, U.-S., Gong, Q., & Huen, M. S. Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616602114 · Cited by 59
Sarkari, F., Wang, X., Nguyen, T., & Frappier, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016598 · Cited by 59
“Immunofluorescence microscopy was performed as previously described [36] using primary antibodies for USP7 [32], PML (PGM3, Santa Cruz) or myc (Rabbit A-14 from Santa Cruz or mouse monoclonal 9E10, kindly provided by Dr.”
BackgroundMethodSelf-citationFhu, C. W., & Ali, A. (2021) · Cancers · doi:10.3390/cancers13071513 · Cited by 64
“Identified in 1997, ubiquitin-specific protease 7 (USP7) was first characterized to interact with herpes simplex virus type 1 (HSV-1) immediate-early protein (Vmw110) of the HSV-1 regulatory protein and other viral proteins [124,125].”
MethodNayyar, V. K., Shire, K., & Frappier, L. (2009) · Journal of Cell Science · doi:10.1242/jcs.060913 · Cited by 58
“, 2004), although the same sequences are known to interact with at least a few different cellular proteins (Holowaty et al., 2003; Shire et al., 1999; Snudden et al., 1994; Van Scoy et al., 2000; Wang et al., 1997).”
BackgroundSelf-citationThe USP7 protein interaction network and its roles in tumorigenesis
Al-Eidan, A., Wang, Y., Skipp, P., & Ewing, R. M. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2020.10.004 · Cited by 57
“According to the findings, USP7 is capable of regulating of EBNA1, whereas EBNA1 might have an impact on the cellular process through the sequestering of important regulatory proteins.(58,62)”
BackgroundHegde, N. R., Chevalier, M. S., Wisner, T. W., Denton, M. C., Shire, K., Frappier, L., & Johnson, D. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602989200 · Cited by 57
Self-citationWang, S., & Frappier, L. (2009) · Journal of Virology · doi:10.1128/jvi.00931-09 · Cited by 60
“Note that the major peptides identified as NAP1 in matrix-assisted laser desorption ionization–time-offlight analyses from the EBNA1 affinity column experiments (28) are also present in NAP2, and additional peptides were recovered that match only NAP1 or NAP2 (but not both), suggesting that both NAP1 and NAP2 were pre…”
BackgroundMethodSelf-citationSarkari, F., La Delfa, A., Arrowsmith, C. H., Frappier, L., Sheng, Y., & Saridakis, V. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.017 · Cited by 54
Self-citationEpstein–Barr virus oncogenesis and the ubiquitin–proteasome system
Masucci, M. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207372 · Cited by 60
“USP7 was shown to bind and deubiquitinate p53, resulting in p53 stabilization and p53-dependent growth arrest and apoptosis (Boutell and Everett, 2003).”
BackgroundInfluentialShechter, O., Sausen, D. G., Gallo, E. S., Dahari, H., & Borenstein, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214389 · Cited by 57
HAUSP/USP7 as an Epstein–Barr virus target
Holowaty, M. N., & Frappier, L. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320731 · Cited by 48
Self-citationProteome Changes Induced by Knock-Down of the Deubiquitylating Enzyme HAUSP/USP7
Kessler, B. M., Fortunati, E., Melis, M., Pals, C. E. G. M., Clevers, H., & Maurice, M. M. (2007) · Journal of Proteome Research · doi:10.1021/pr0702161 · Cited by 47
Malik-Soni, N., & Frappier, L. (2012) · Journal of Virology · doi:10.1128/jvi.00194-12 · Cited by 47
“We also detected interactions of EBNA1 with the related nucleosome assembly proteins TAF-I (also called SET) and NAP1, previously isolated from HeLa lysates on EBNA1 affinity columns and subsequently shown to contribute to EBNA1 functions in transcriptional activation and DNA replication (10, 28).”
BackgroundMethodSelf-citationMa, X., Bartczak, A. M., Zhang, J., Khattar, R., Chen, L., Liu, M. F., Edwards, A. M., Levy, G. A., & McGilvray, I. D. (2010) · Journal of Virology · doi:10.1128/jvi.01219-10 · Cited by 45
“For example, EpsteinBarr virus and herpes simplex virus proteins interact with the host deubiquitinating (DUB) protein USP7 (13, 17).”
BackgroundViral proteomics: global evaluation of viruses and their interaction with the host
Viswanathan, K., & Früh, K. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.6.815 · Cited by 47
Deubiquitinases in Neurodegeneration
Bello, A. I., Goswami, R., Brown, S. L., Costanzo, K. M., Shores, T., Allan, S. K., Odah, R., & Mohan, R. D. (2022) · Cells · doi:10.3390/cells11030556 · Cited by 49
USP7 Regulates Cytokinesis through FBXO38 and KIF20B
Georges, A. A., Coyaud, É., Marcon, E., Greenblatt, J. F., Raught, B., & Frappier, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39368-y · Cited by 45
Self-citationZhou, H., Liu, Y., Wang, C., Liu, L., Wang, H., Zhang, Y., Long, C., & Sun, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0865-5 · Cited by 41
Nasimuzzaman, M., Kuroda, M., Dohno, S., Yamamoto, T., Iwatsuki, K., Matsuzaki, S., Rashel, M., Kumita, W., Mizuguchi, H., Hayakawa, T., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.017 · Cited by 41
Epstein-Barr Virus Nuclear Antigen 1 Does Not Cause Lymphoma in C57BL/6J Mice
Kang, M.-S., Soni, V., Bronson, R. T., & Kieff, E. D. (2008) · Journal of Virology · doi:10.1128/jvi.02596-07 · Cited by 50
“EBNA1 overexpression can displace p53 from USP7, enhance p53 degradation, and protect cells from apoptosis (18, 40), consistent with the possibility that even threefold EBNA1 overexpression might increase pulmonary adenoma prevalence in FVB mice.”
BackgroundGredmark, S., Schlieker, C. D., Quesada, V., Spooner, E., & Ploegh, H. L. (2007) · Journal of Virology · doi:10.1128/jvi.01149-07 · Cited by 41
“We have cloned and expressed the putative catalytic domain from murine cytomegalovirus (MCMV) and from EBV and have shown that both, when expressed recombinantly in Escherichia coli, possess enzymatic activity (22), as confirmed by crystallographic analysis of the MCMV M48 product in a complex with ubiquitin-vinylmeth…”
InfluentialGillen, J., Li, W., Liang, Q., Avey, D. R., Wu, J., Wu, F., Myoung, J., & Zhu, F. (2015) · Journal of Virology · doi:10.1128/jvi.02925-14 · Cited by 45
“The latent protein 567 EBNA1 of EBV has been shown to bind with USP7 through the same region as p53 (58).”
BackgroundHAUSP as a therapeutic target for hematopoietic tumors (review)
Cheon, K., & Baek, K.-H. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1209 · Cited by 37
Ribeiro, M. M. B., Franquelim, H. G., Castanho, M. A. R. B., & Veiga, A. S. (2007) · Journal of Peptide Science · doi:10.1002/psc.939 · Cited by 37
USP7 manipulation by viral proteins
Bojagora, A., & Saridakis, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198076 · Cited by 38
Wang, J.-D., & Sugden, B. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20324 · Cited by 37
“…and genetic approaches: yeast two hybrid assays; yeast one hybrid assays using DS; and protein affinity purification using purified EBNA1 as a ligand [Fischer et al., 1997; Kim et al., 1997; Wang et al., 1997; Aiyar et al., 1998; Shire et al., 1999; Ito et al., 2000; Holowaty et al., 2003].”
MethodTargeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects
Yeasmin Khusbu, F., Chen, F., & Chen, H. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3336 · Cited by 36
Research landmarks on the 60th anniversary of Epstein-Barr virus
Zhong, L., Xie, C., Zhang, L., Yang, Y.-L., Liu, Y.-T., Zhao, G., Bu, G., Tian, X.-S., Jiang, Z., Yuan, B., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2766-0 · Cited by 39
“However, compared with p53 and MDM2, EBNA1 has a greater affinity, enabling it to competitively interfere with the activities of p53 and MDM2 (Holowaty et al., 2003a; Saridakis et al., 2005).”
Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas
Pei, Y., Wong, J. H.-Y., & Robertson, E. S. (2020) · Cancers · doi:10.3390/cancers12092565 · Cited by 37
“EBNA1 can interact with the ubiquitin-specific protease HAUSP/USP7 and competitively binds to its cellular partners p53 and MDM2, which mediates p53 degradation and inhibits apoptosis [38,39].”
BackgroundDeubiquitinating Enzymes as Promising Drug Targets for Infectious Diseases
Nanduri, B., Suvarnapunya, A. E., Venkatesan, M. M., & Edelmann, M. J. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180008 · Cited by 38
USP7 protects genomic stability by regulating Bub3.
Giovinazzi, S., Sirleto, P., Aksenova, V., Morozov, V. M., Zori, R., Reinhold, W. C., & Ishov, A. M. (2014) · Oncotarget · doi:10.18632/oncotarget.1989 · Cited by 34
“The deubiquitylating enzyme USP7 is a critical regulator of cellular processes through regulation of stability of tumor suppressors, such as p53 and PTEN [29] [30, 31], DNA damage response proteins [32], transcription factors [33, 34], viral proteins [35-39], epigenetic modulators [40-44] and mitotic regulators [45, 4…”
BackgroundIdentification of a Novel Protein Interaction Motif in the Regulatory Subunit of Casein Kinase 2
Cao, J. Y., Shire, K., Landry, C. H., Gish, G. D., Pawson, T. J., & Frappier, L. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00968-13 · Cited by 34
“EBNA1 (R4 rabbit serum at 1:300 dilution) (25), PML (PG-M3 at 1:50”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Holowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J., & Frappier, L.
- Affiliations
- University of Toronto (CA)
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Frappier, Lori
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 278
- Issue
- 32
- Pages
- 29987-29994
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2031857756
- Cited by
- 228
- References
- 55
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 4 · 2023: 5 · 2022: 13 · 2021: 9 · 2020: 8 · 2019: 14 · 2018: 8 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 10 · 2013: 15 · 2012: 13
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6269 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- EBNA1, Epstein-Barr virus, ubiquitin-specific protease, protein-protein interaction, NAP1, sets, casein kinase 2, PRMT5, latent viral genome
- MeSH terms
- Ubiquitin-Specific Peptidase 7, Animals, Cell Line, Chromatography, Affinity, Electrophoresis, Polyacrylamide Gel, HeLa Cells, Humans, Insecta, Microscopy, Fluorescence, Models, Genetic, Mutation, Endopeptidases, Plasmids, Precipitin Tests, Protein-Arginine N-Methyltransferases, Protein Binding, Protein Methyltransferases, Sodium Chloride, Mass Spectrometry, Transcriptional Activation, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Epstein-Barr Virus Nuclear Antigens, Ubiquitin Thiolesterase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.